Meitheal Pharmaceuticals, Inc: FDA recalls
FDA enforcement events from 2021 to 2026; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.
FDA enforcement reports name Meitheal Pharmaceuticals, Inc as the recalling firm in 3 events. The events have 3 product records. The recalls started from 2021 to 2026. All the events are drug recalls. By FDA enforcement events, Meitheal Pharmaceuticals, Inc is number 1,113 of 1,628 firms that have a page. Events that Meitheal Pharmaceuticals, Inc started: none in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025.
It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.
FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .
Enforcement events
3 events, newest first.
| Initiated | Product (first record) | Type | Class | Records | Status |
|---|---|---|---|---|---|
| 9 Feb 2026 | Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90. | Drug | Class II | 1 | Ongoing |
| 3 Sep 2021 | Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21 | Drug | Class III | 1 | Terminated |
| 27 Jan 2021 | Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06), Rx only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL 60631. | Drug | Class I | 1 | Terminated |
An event with 1 product record and a class that is not Class I has no page. It has a row in this table.
Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.
Recalling firm: The firm that the FDA record names for a recall.
Follow by RSS:Food, drug and device recallsFDA Class I recalls
Type and class
| Type | Events |
|---|---|
| Drug | 3 |
| Class | Events |
|---|---|
| Class I | 1 |
| Class II | 1 |
| Class III | 1 |
- Share of the events of the firm in Class I
- 33%
- Share of all events on the register in Class I
- 18%
- Events with the status Ongoing
- 1
openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.
Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.
Events by year
Official channels
- FDA enforcement reportsThe FDA search of the weekly enforcement reports.
- FDA: recalls, market withdrawals and safety alertsThe recall notices on the FDA site.
- FDA: report a problemThe FDA page that shows where a report about a product goes.
- FDA MedWatchThe FDA safety reporting program for drugs and medical devices.
Cite this page
Recall Register. Meitheal Pharmaceuticals, Inc: FDA recalls. https://recallregister.com/firm/meitheal-pharmaceuticals-inc/. Source: openFDA enforcement reports. Data through .
Sources
- Source
- openFDA enforcement reports
- Licence
- CC0 1.0
- Export date
- 3 Nov 2026
- State of the firm address
- IL
The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.
A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.
Questions
- Which classes do the FDA recalls of Meitheal Pharmaceuticals, Inc have?
- Class I: 1 event. Class II: 1 event. Class III: 1 event. The class is for the product of a recall. It is not a class of the firm.
- What is the newest FDA recall of Meitheal Pharmaceuticals, Inc?
- FDA event 98386, which the firm started on 9 Feb 2026. The first product in the record is:
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
- How many FDA recalls of Meitheal Pharmaceuticals, Inc have the status Ongoing?
- 1 event has the status Ongoing in the openFDA file. openFDA says about the status:
FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.